propranolol has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 8 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups." | 5.26 | Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982) |
| "The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups." | 1.26 | Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-García, R | 1 |
| Jofre, R | 1 |
| Vasconez, F | 1 |
| Caballero, A | 1 |
| Valderrábano, F | 1 |
| Pizzarelli, F | 1 |
| Zoccali, C | 1 |
| Ciccarelli, C | 1 |
| Maggiore, Q | 1 |
| Bonucci, E | 1 |
| Ballanti, P | 1 |
| Besarab, A | 2 |
| Caro, JF | 2 |
| Ihle, BU | 1 |
| Burke, JF | 2 |
| Glennon, JA | 2 |
| Fischer, JA | 1 |
| Schaefer, K | 1 |
| Brancaccio, D | 2 |
| Galmozzi, C | 2 |
| Casati, S | 2 |
| Ponticelli, C | 2 |
| Eastwood, JB | 1 |
| Rurale, D | 1 |
| Belloli, S | 1 |
| Aroldi, A | 1 |
| Graziani, G | 1 |
2 trials available for propranolol and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
[Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency].
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; K | 1982 |
A possible role for propranolol in the treatment of renal osteodystrophy.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Diso | 1978 |
6 other studies available for propranolol and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
Topics: Bone Resorption; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Seco | 1982 |
Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
Topics: Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydrotachysterol; | 1981 |
[Therapy of uremic osteopathy].
Topics: Aluminum Hydroxide; Aluminum Oxide; Calcitonin; Chronic Kidney Disease-Mineral and Bone Disorder; Ci | 1980 |
Propranolol in uraemic osteodystrophy.
Topics: Alkaline Phosphatase; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Parathyroid Hormone; | 1978 |
Propranolol in uraemic osteodystrophy.
Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Propranolo | 1979 |
Propranolol and uraemic osteodystrophy.
Topics: Alkaline Phosphatase; Calcitonin; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hydroxyp | 1979 |